GLP and GMP-certified enzyme activity evaluations engineered for natural and synthetic enzymes, enzymatic biomarkers, and targeted inhibitors across complex formulations.
BrownBiology Laboratory delivers high-end enzymatic activity assays strictly governed under GLP/GMP conditions spanning both bioanalytical and comprehensive CMC projects.
By harmonizing deeply specialized scientific expertise with extensive regulatory intelligence, we guarantee statistically reliable, completely validated analytical outputs applicable to robust biological and pharmaceutical formulations.
We define precise enzyme activity by introducing targeted synthetic substrates and longitudinally measuring subsequent product generation and turnover velocity using highly calibrated microtiter plate analytical suites.

We oversee full GLP-validated enzymatic activity tracking across highly variable biological matrices driving preclinical and clinical milestones. This sophisticated methodology is seamlessly derived from progressive EMA Immunological guidelines.
The primary enzymatic reaction is terminated after an exact time period.
The complete enzymatic sequence is continuously monitored per strict time unit.
Our facility supplies uncompromising GMP-certified Quality Control networks alongside integrated CMC portfolios curated for enzyme-based therapeutics and molecular inhibitors.
All downstream analytical testing aligns directly with global Pharmacopoeial configurations (Ph. Eur., USP) minimizing submission friction.
Our teams maintain mature infrastructure required to handle robust activity assays transversing highly complex biomolecules.
Deep profiling spanning specialized proteins including functional variants of trypsin, specific pepsin formats, serine proteases, and targeted carboxypeptidase constructs.
Robust analysis structures supporting metabolic profiling and formulation verification (e.g. phospholipase integrity, colipase functions, complex cholesterol esterases).
Extensive kinetic capability tracking and validating broad-spectrum hydrolase activity networks encompassing standard amylase, localized lysozymes, target cellulase, and lactase matrices.
Our enzyme activity testing complies with ICH guidelines and is validated under GLP or GMP conditions to support global regulatory submissions (EMA, FDA, etc.).
We offer rapid timelines, deeply personalized services, and highly proactive communication to keep your analytical project on track and accelerate your time-to-market.
BrownBiology uniquely integrates both GLP bioanalytical services and GMP CMC testing, enabling comprehensive project support across the entire drug development lifecycle.
We pioneer fit-for-purpose enzyme activity assays, skillfully adapting complex analytical approaches to specific molecule properties and exacting regulatory demands.
Bring molecular predictability to your innovative therapeutics. Whether you require robust protease screenings, specialized lipase baselines, or customized inhibitor evaluations.
Request a Project Proposal